Aspire Biopharma to Acquire Automotive Supplier Dura Driver for $30M, Adding $200M+ Revenue
ASBP sits 82% above its 52-week low of $3.309 on elevated volume (13× avg).
Summary
Aspire Biopharma has signed a definitive agreement to acquire Dura Driver Control Systems, an automotive supplier, for $30 million in cash. This follows a non-binding letter of intent announced on April 15th and an 8-K filed earlier today confirming the $30 million acquisition. Dura Driver generated over $200 million in revenue and $22 million in Adjusted EBITDA in 2025. The acquisition price is roughly four times Aspire's current market capitalization, representing a transformative strategic shift and significant diversification into the industrial sector. The company does not anticipate new equity financing for the transaction, which is a positive given its history of dilutive financing. The transaction is expected to close in Q3 2026.
At the time of this announcement, ASBP was trading at $6.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.8M. The 52-week trading range was $3.31 to $1,050.36. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.